Ferric nitrilotriacetate induces oxidative damage in renal proximal tubules, a consequence of Fenton-like reaction, that ultimately leads to a high incidence of renal cell carcinoma (RCC) in rats. In order to ®nd common genetic alterations in this oxystress-induced carcinogenesis model, RCCs were produced in F1 hybrid rats between Wistar and Long-Evans strains and genomes were screened for loss of heterozygosity (LOH) with microsatellite polymorphic markers by PCR. Five consecutive markers on chromosome 5 (D5Mgh5, D5Mit9, D5Mgh6, D5Mit11 and D5Mit6) showed LOH in 40% of the RCCs. As possible candidate tumor suppressor genes on chromosome 5, p15
Ferric nitrilotriacetate induces oxidative damage in renal proximal tubules, a consequence of Fenton-like reaction, that ultimately leads to a high incidence of renal cell carcinoma (RCC) in rats. In order to ®nd common genetic alterations in this oxystress-induced carcinogenesis model, RCCs were produced in F1 hybrid rats between Wistar and Long-Evans strains and genomes were screened for loss of heterozygosity (LOH) with microsatellite polymorphic markers by PCR. Five consecutive markers on chromosome 5 (D5Mgh5, D5Mit9, D5Mgh6, D5Mit11 and D5Mit6) showed LOH in 40% of the RCCs. As possible candidate tumor suppressor genes on chromosome 5, p15
INK4B and p16 INK4A were investigated for genetic alteration and aberrant methylation by Southern blot, PCR/SSCP/ sequencing and methylation-speci®c PCR. Genetic alteration (homozygous or hemizygous deletion with or without point mutation) or aberrant methylation were found in 30.7 and 53.8% of the RCC cases, respectively, which was proportionally associated with the histological nuclear grade and metastatic activity. Our data suggest that inactivation of p15 and p16 genes could be one of the major pathways responsible for oxystress-induced carcinogenesis.
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; methylation, rat An iron chelate, ferric nitrilotriacetate (Fe-NTA), induces renal proximal tubular damage, a consequence of Fenton-like reaction, that ultimately leads to a high incidence of renal cell carcinoma (RCC) in rats (Ebina et al., 1986) . This is a unique model characterized by (1) high incidence of pulmonary metastasis and peritoneal invasion (2) high incidence of tumorassociated mortality (Nishiyama et al., 1995) , and (3) possible involvement of reactive oxygen species (ROS) in the carcinogenic process. Oxidatively modi®ed molecules we found increased in the kidney after Fe-NTA treatment include DNA base modi®cations such as 8-oxoguanine, thymine-tyrosine cross-links, thiobarbituric acid-reactive substances, saturated and unsaturated mutagenic aldehydes such as 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA), and HNE-or MDA-modi®ed proteins (Toyokuni et al., 1994a,b ; see review by Toyokuni, 1996 Toyokuni, , 1999 .
Due to its resemblance to human RCCs of non clear-cell subtype (Nishiyama et al., 1995) and the close association of carcinogenesis with oxidative damage (Toyokuni, 1996) , it would be of interest to ®nd the target gene(s) in this RCC model. We have thus far searched for genetic alterations in several candidate genes including H-, K-and N-ras oncogenes and p53, VHL and Tsc2 tumor suppressor genes. However, there was a low or no incidence of genetic alteration in the coding region of these genes (Nishiyama et al., 1995; Toyokuni et al., 1998) . Here, we have taken a strategy to scan the genome of Fe-NTA-induced RCC s in F1 hybrid rats between Wistar (Shizuoka Laboratory Animal Center, Shizuoka, Japan) and Long-Evans (originally outbred from Ben May Laboratory for Cancer Research, University of Chicago, IL, USA) (Osaka et al., 1995) strains for loss of heterozygosity (LOH) with microsatellite polymorphic markers by PCR.
Fe-NTA was administered as previously described (Nishiyama et al., 1995) and 39 primary tumors of ample size were selected for the present study out of 83 F1 hybrid rats. Forty primer pairs (Research Genetics, Huntsville, AL, USA) polymorphic between the two strains were selected (data not shown). A preliminary experiment (23 RCCs) revealed a signi®cantly high frequency of LOH (430%) on chromosomes 5 and 8 (D8Mit5). We then focused on chromosome 5 and collected data on all the RCCs. All the microsatellite markers appropriate for analysis (D5Mgh5, D5Mit9, D5Mgh6, D5Mit11, D5Mit6) showed LOH of 40% (Table 1) . No preference was observed to either strain as lost allele in the LOH cases. Since LOH suggests the presence of tumor suppressor gene(s) according to the Knudson's`two hit theory' (Knudson et al., 1975) , we searched for candidate genes from the map position using the Jackson Laboratory Mouse Genome Informatics Mouse Genome Database (http:// www.informatics.jax.org). p15 INK4B (p15) and p16
(p16) were the only candidate genes reported thus far at the map position indicated. We then evaluated whether these two genes are one of the targets for carcinogenesis. RCCs were classi®ed into three groups solely by nuclear morphology on hematoxylin and eosin-stained specimens as described (Nishiyama et al., 1995) . Representative Southern blot results are shown in Figure 1 . WT1 tumor suppressor gene located on chromosome 3 was used as a control. Heterozygous deletion was de®ned as 560% of the WT1 density, and homozygous deletion as 510%. Southern blot data is summarized in Table 1 . There was a signi®cant correlation between the nuclear grade and the fraction of LOH-positive cases for p15 and p16 (r=0.997; r=0.994, respectively). Oligonucleotide primers for the production of Southern and Northern blot probes and for SSCP analyses of p15 (Hino et al., 1995) and p16 (Swaord et al., 1997) were determined by Geneworks version 2.5.1 software (IntelliGenetics, Inc., Mountain View, CA, USA) and synthesized. Sequences of the primers are available on request.
Studies were then conducted to ®nd potentially inactivating intragenic mutations in the remaining allele of either gene in the cases of hemizygous deletion as well as in the cases without LOH in p15 and p16. PCR/SSCP analysis in two cases for each gene with hemizygous deletion showed shifted bands (data not shown). Each shifted band was cut out from the gel and the DNA was extracted followed by subcloning and sequencing as described (Toyokuni et al., 1998) . In p15, one mutation was found at codon 9, GGC (Gly) to GAC (Asp) in exon 1; the other was at codon 87, ACG (Thr) to ACA (Thr, silent) in exon 2. In p16, one mutation was found at codon 9, GCC (Ala) to GC (one base deletion with frameshift) in exon 1; the other was found at codon 16, CGT (Arg) to CAT (His) in exon 1. The three missense mutations were accompanied by LOH (Table 1) theoretically leading to the loss of oncosuppression. 
As another mechanism of inactivating p15 and p16, methylation of 5' CpG island region of both genes were evaluated by methylation-speci®c PCR. Methylation was observed in 2.5% for p15 and 33.3% for p16 (Figure 2 ). Seven cases were accompanied by LOH probably leading to the loss of oncosuppression in p16. Methylation of p16 was proportionally associated with the grade of tumor (r=0.976).
Expression of p15 and p16 was assessed in the selected 15 cases with allelic loss (Figure 4) . If either homozygous deletion, hemizygous deletion with point mutation or hemizygous deletion with methylation is hypothesized to result in the activation of p15 and p16, ®ve out of eight cases with no p16 expression were concordant with the hypothesis; however, no p16 expression was found in three cases (No. 19, 30, 34) with hemizygous deletion. Four out of ®ve cases with no p15 expression were concordant with the hypothesis; all the four cases were homozygous deletion and the inconsistent case (No. 8) was with hemizygous deletion.
All the molecules in our body including DNA are persistently exposed to the attacks of ROS, and this has been considered as one of the causes of carcinogenesis (Halliwell and Aruoma, 1993) . Iron plays a role as a catalyst for the generation of ROS through the Fenton reaction. A number of epidemiological or experimental reports support the association Table 1 . Methylation-speci®c PCR was done as described (Herman et al., 1996a) with minor modi®cation. Brie¯y, 5 mg genomic DNA were treated with 3 M sodium bisul®te and 10 mM hydroquinone, puri®ed with the Wizard DNA puri®cation systems (Promega, Madison, WI, USA) and desulfonated with 0.3 M NaOH. PCR ampli®cation was done with approximately 300 ng of treated DNA as template. Primers for p16 were synthesized as previously reported (Swaord et al., 1997) . Primers for p15 genes were designed to examine methylation status of 5' CpG island throughout exon 1 of p15 (Figure 3 ). Two sets of the primers were designed, one speci®c for DNA methylated at CpG sites and the other speci®c for fully unmethylated. Ampli®cation was carried out in a 50 ml reaction mixture. Mixtures were denatured at 958C for 5 min followed by 35 cycle of 958C for 30 s, 518C for 30 s and 728C for 30 s. In the last cycle, the 728C step was extended to 5 min. After incubation, 10 ml of the PCR products were electrophoresed on 4% Nusieve GTG agarose gel (FMC Bioproducts, Rockland, ME, USA) to con®rm speci®c ampli®cation of the targeted fragment Figure 3 Setting of the primers for methylation-speci®c PCR of the rat p15. Location and orientation of the primers are indicated by the arrows under the sequence. Seven CpG sites examined (numbered 1 ± 7), the start codon and the G/C box are boldfaced. Details of the primers used are available on request Figure 4 Northern blot analysis of p15 and p16 in the Fe-NTAinduced RCCs. Case numbers correspond to those of Table 1 . Poly(A) + RNA (8 mg) was loaded to each lane, and the visualization was done with BAS2000 (Fiji Film, Tokyo, Japan). The exposure time was 48 h for p15 and p16 while 3 h for b-actin p15/p16 inactivation in oxystress-induced cancer T Tanaka et al of iron overload with carcinogenesis (Toyokuni, 1996) . Thus Fe-NTA-induced renal carcinogenesis presents an intriguing model in that Fenton-like reaction in vivo indeed leads to cancer of highly malignant potential (Nishiyama et al., 1995; Toyokuni, 1996) . Considering the non-speci®c nature of ROS reactions, it is important to determine whether certain target genes are selectively damaged by ROS or the whole genome is randomly damaged. Our results clearly demonstrated the presence of target tumor suppressor genes on chromosome 5 and 8.
Candidate tumor suppressor genes, p15 and p16 coding cyclin-dependent kinase inhibitors, has been recently isolated, and found to be inactivated by homozygous deletion or hypermethylation of 5' CpG island region in many types of tumor cell lines or primary tumors of humans (Cairns et al., 1995a; Herman et al., 1996b) . The present study showed a high incidence of homozygous or hemizygous deletion of each gene in Fe-NTA-induced rat RCCs. As far as we know, such a high incidence of homozygous or hemizygous deletion of p15 and p16 tumor suppressor genes has never been reported in the primary animal tumors. A high frequency of allelic loss in the both genes may re¯ect an increase in Fe-NTA-induced double strand breaks in DNA as we reported in in vitro experiments (Toyokuni and Sagripanti, 1993) . Why p15 and p16 are selectively aected, namely, whether the deletion is associated with their function, physical gene structure or chromosomal location is an intriguing question to be answered from the viewpoint of ROS.
The spectrum of point mutation in p15 or p16 were three G : C to A : T transitions and one C deletion. These mutations were observed only in the cases with hemizygous deletion of p15 or p16. This strongly suggests that hemizygous or homozygous deletion rather than point mutation is preceding in p15 and p16 and is a critical step in carcinogenesis. C : G to T : A transition by oxidative damage has been reported in in vitro experiments (McBride et al., 1991) . Increased oxidative damage in cytosine after Fe-NTA administration (Toyokuni et al., 1994a) might be responsible for the induced point mutations.
We found a high incidence of methylation in p16 (Table 1) . Some discrepancies observed between the genetic alteration/methylation and expression could be due to an underestimation of homozygous deletion by inevitable contamination of non-tumor cells. The result after all emphasizes a similarity of this rat carcinogenesis model to human cancers. We may inversely hypothesize that etiology of human cancers with p15 and p16 inactivation either by deletion or methylation is associated with endogenous or exogenous ROS.
However, this awaits further investigation to be demonstrated.
Interestingly, biological behavior of the RCCs with inactivation of p15 or p16 were mostly high-grade, metastatic and invasive. A high frequency of p15 and p16 inactivation in cultured cell lines but not in primary tumors have been observed in several types of cancer including renal cell carcinoma. For example, it was reported that while 470% of RCC cell lines derived from Eker rats exhibited homozygous deletion of either p15 or p16, primary RCCs showed deletion in neither p15 nor p16 (Knapek et al., 1995) . RCCs in Eker rats are indeed low-grade, not metastatic, and rarely fatal (Hino et al., 1994) .
According to the Oxford grid, rat chromosome 5 is syntenic to human chromosome 1 and 9. Reportedly, 9p LOH, homozygous deletion of 9p21-22 and selective deletion of 9q occurred with a high frequency in primary human RCCs with no genetic alteration in p16 (Cairns et al., 1995b) . A high incidence of LOH at 1p is also reported in human RCCs (Schwerdtle et al., 1996) . These and our results suggest that there are other target genes involved in renal carcinogenesis on rat chromosome 5 than p15 and p16.
In conclusion, p15 and p16 genes are two of the major target genes in this ROS-induced rat renal carcinogenesis model. As far as we know, this is the ®rst report of a high incidence of homozygous or heterozygous deletion of p15/p16 in primary cancer, not in cultured cells, of animal carcinogenesis model. In humans, there have been few studies on the genetic alterations in RCCs of non-clear cell subtype. This model oers a good opportunity not only to ®nd new genes responsible for high-grade, non-clear cell subtype RCCs but also to ®nd clues between oxidative stress and carcinogenesis.
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